BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11694646)

  • 21. Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7.
    Fleming Y; Armstrong CG; Morrice N; Paterson A; Goedert M; Cohen P
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):145-54. PubMed ID: 11062067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
    Fu YM; Lin H; Liu X; Fang W; Meadows GG
    J Cell Physiol; 2010 Aug; 224(2):491-500. PubMed ID: 20432447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of MKK4, MKK6 and MKK7 during prostate cancer progression: an important role for SAPK signalling in prostatic neoplasia.
    Lotan TL; Lyon M; Huo D; Taxy JB; Brendler C; Foster BA; Stadler W; Rinker-Schaeffer CW
    J Pathol; 2007 Aug; 212(4):386-94. PubMed ID: 17577251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SEK1/MKK4-mediated SAPK/JNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis.
    Watanabe T; Nakagawa K; Ohata S; Kitagawa D; Nishitai G; Seo J; Tanemura S; Shimizu N; Kishimoto H; Wada T; Aoki J; Arai H; Iwatsubo T; Mochita M; Watanabe T; Satake M; Ito Y; Matsuyama T; Mak TW; Penninger JM; Nishina H; Katada T
    Dev Biol; 2002 Oct; 250(2):332-47. PubMed ID: 12376107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-type-specific activation of p38 protein kinase cascades by the novel tumor promoter palytoxin.
    Li S; Wattenberg EV
    Toxicol Appl Pharmacol; 1999 Oct; 160(2):109-19. PubMed ID: 10527909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells.
    Núñez NP; Liu H; Meadows GG
    Cancer Lett; 2006 May; 236(1):133-41. PubMed ID: 15979236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.
    Fu YM; Yu ZX; Ferrans VJ; Meadows GG
    Nutr Cancer; 1997; 29(2):104-13. PubMed ID: 9427972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
    Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
    Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
    Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
    Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
    Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
    Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3.
    Lin J; Tang H; Jin X; Jia G; Hsieh JT
    Oncogene; 2002 May; 21(19):3082-8. PubMed ID: 12082540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
    Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
    Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures.
    Elstad CA; Meadows GG
    Anticancer Res; 1993; 13(2):523-8. PubMed ID: 8517667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomewide RNAi screen identifies protein kinase Cb and new members of mitogen-activated protein kinase pathway as regulators of melanoma cell growth and metastasis.
    Schönherr M; Bhattacharya A; Kottek T; Szymczak S; Köberle M; Wickenhauser C; Siebolts U; Saalbach A; Koczan D; Magin TM; Simon JC; Kunz M
    Pigment Cell Melanoma Res; 2014 May; 27(3):418-30. PubMed ID: 24406113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanoma.
    Packer LM; East P; Reis-Filho JS; Marais R
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):785-98. PubMed ID: 19682280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of FOXM1 as a Potential New Target for Melanoma.
    Miyashita A; Fukushima S; Nakahara S; Yamashita J; Tokuzumi A; Aoi J; Ichihara A; Kanemaru H; Jinnin M; Ihn H
    PLoS One; 2015; 10(12):e0144241. PubMed ID: 26640950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2.
    Yip-Schneider MT; Lin A; Marshall MS
    Biochem Biophys Res Commun; 2001 Feb; 280(4):992-7. PubMed ID: 11162624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.